Mechanisms of action of antimicrobials: Focus on fluoroquinolones

Clinical Infectious Diseases

Volumn 32, Issue SUPPL. 1, 2001, Pages

  Hooper, D C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 PYRIDONE DERIVATIVE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; BACTERIAL DNA; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; COUMARIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; GLYCOPEPTIDE; KETOLIDE; LINCOSAMIDE; MACROLIDE; NAPHTHYRIDINE DERIVATIVE; OXAZOLIDINONE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; RIFAMYCIN; STREPTOGRAMIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; BACTERIAL CELL WALL; BACTERIAL METABOLISM; BACTERICIDAL ACTIVITY; BACTERIUM MUTANT; CELL DEATH; COMPLEX FORMATION; CYTOTOXICITY; DNA FLANKING REGION; DNA REPLICATION; DNA STRAND BREAKAGE; DNA SYNTHESIS; DRUG ACTIVITY; DRUG DNA BINDING; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG TARGETING; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RNA SYNTHESIS;

ANTI-INFECTIVE AGENTS; CELL WALL; FLUOROQUINOLONES; NUCLEIC ACID SYNTHESIS INHIBITORS; QUINOLONES;

EID: 0035866965     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/319370     Document Type: Review

References (58)

1. Inhibition of peptidoglycan biosynthesis by ramoplanin
2. Multimodular penicillin-binding proteins: An enigmatic family of orthologs and paralogs
3. β-lactam resistance in Streptococcus pneumoniae: Penicillin-binding proteins and non-penicillin-binding proteins
4. Vancomycin resistance: Structure of D-alanine:D-alanine ligase at 2.3 Å resolution
5. Vancomycin derivatives that inhibit peptidoglycan biosynthesis without binding D-Ala-D-Ala
6. Vancomycin-resistant enterococci
7. hipA, a newly recognized gene of Escherichia coli K-12 that affects frequency of persistence after inhibition of murein synthesis
8. Conditional impairment of cell division and altered lethality in hipA mutants of Escherichia coli K-12
9. Isolation and characterization of an Escherichia coli strain exhibiting partial tolerance to quinolones
10. Multiple antibiotic resistance in a bacterium with suppressed autolytic system
11. Insertional inactivation of the major autolysin gene of Streptococcus pneumoniae
12. LytB, a novel pneumococcal murein hydrolase essential for cell separation
13. Emergence of vancomycin tolerance in Streptococcus pneumoniae
14. In vivo characterization of the type A and B vancomycin-resistant enterococci (VRE) VanRS two-component systems in Escherichia coli: A nonpathogenic model for studying the VRE signal transduction pathways
15. Isolation and characterization of vancomycin-tolerant Streptococcus pneumoniae from the cerebrospinal fluid of a patient who developed recrudescent meningitis
16. Two bactericidal targets for penicillin in pneumococci: Autolysis-dependent and autolysis-independent killing mechanisms
17. Signal transduction by a death signal peptide: Uncovering the mechanism of bacterial killing by penicillin
18. Escherichia coli K-12 mutants resistant to nalidixic acid: Genetic mapping and dominance studies
19. Quinolone-resistant mutations of the gyrA gene of Escherichia coli
20. gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli
21. New topoisomerase essential for chromosome segregation in E. coli
22. Analysis of gyrA and grlA mutations in stepwise-selected ciprofloxacin-resistant mutants of Staphylococcus aureus
23. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: A primary target of fluoroquinolones
24. Quinolone resistance mutations in topoisomerase IV: Relationship of the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase the secondary target of fluoroquinolones in Staphylococcus aureus
25. Topoisomerase IV is a target of quinolones in Escherichia coli
26. Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of parE gene encoding a subunit of topoisomerase IV
27. Limitations of plasmid complementation test for determination of quinolone resistance due to changes in the gyrase A protein and identification of conditional quinolone resistance locus
28. Mechanisms of quinolone resistance
29. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: Novel pleiotropic effects on quinolone and coumarin activity
30. ParC and GyrA may be interchangeable initial targets of some fluoroquinolones in Streptococcus pneumoniae
31. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases
32. Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: Selective targeting of gyrase or topoisomerase IV by quinolones
33. DNA gyrase and topoisomerase IV are dual targets of clinafloxacin action in Streptococcus pneumoniae
34. Primary targets of fluoroquinolones in Streptococcus pneumoniae
35. Streptococcus pneumoniae DNA gyrase and topoisomerase IV: Overexpression, purification, and differential inhibition by fluoroquinolones
36. Activities of fluoroquinolones against Streptococcus pneumoniae type II topoisomerases purified as recombinant proteins
37. Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus
38. Mechanisms and frequency of resistance to moxifloxacin in comparison with ciprofloxacin in Staphylococcus aureus
39. Pharmacokinetics of a once-daily oral dose of moxifloxacin (BAY 12-8039), a new enantiomerically pure 8-methoxy quinolone
40. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
41. Complete genome sequence of Treponema pallidum, the syphilis spirochete
42. The complete genome sequence of the gastric pathogen Helicobacter pylori
43. Structure and mechanism of DNA topoisomerase II
44. Crystal structure of the breakage-reunion domain of DNA gyrase
45. Crystallization of inhibitor complexes of an N-terminal 24 kDa fragment of the DNA gyrase B protein
46. A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex
47. Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands
48. The mechanism of inhibition of topoisomerase IV by quinolone antibacterials
49. Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: Different patterns of quinolone-induced inhibition of DNA synthesis
50. DNA strand cleavage is required for replication fork arrest by a frozen topoisomerase-quinolone-DNA ternary complex
51. Interactions between DNA helicases and frozen topoisomerase IV-quinolone-DNA ternary complexes
52. DNA gyrase on the bacterial chromosome: Possibility of two levels of action
53. Bipolar localization of Bacillus subtilis topoisomerase IV, an enzyme required for chromosome segregation
54. The complex of DNA gyrase and quinolone drugs with DNA forms a barrier to transcription by RNA polymerase
55. DNA cleavage is not required for the binding of quinolone drugs to the DNA gyrase-DNA complex
56. DNA gyrase, topoisomerase IV, and the 4-quinolones
57. The mode of action of quinolones: The paradox in activity of low and high concentrations and activity in the anaerobic environment
58. Bactericidal mechanisms of ofloxacin